WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics Inc. (MYGN):
-Earnings: -$115.2 million in Q3 vs. $6.9 million in the same period last year. -EPS: -$1.55 in Q3 vs. $0.09 in the same period last year. -Analysts projected $0.02 per share -Revenue: $164.0 million in Q3 vs. $216.6 million in the same period last year.
Copyright RTT News/dpa-AFX
© 2020 AFX News